Nevertheless, the specific mechanisms and anti-tumor effects of NK-exos stimulated with IL-15 and other cytokines such as IL-21 (NK-exosIL−15/21) in solid tumors, including HCC, remain unclear. This evidence concerns the gene IL21 and hepatocellular carcinoma.